Connection

Dongliang Yang to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Dongliang Yang has written about Treatment Outcome.
Dongliang Yang
Connection Strength
0.047
Treatment Outcome
  1. Predictors for efficacy of combination therapy with a nucleos(t)ide analogue and interferon for chronic hepatitis B. J Huazhong Univ Sci Technolog Med Sci. 2017 Aug; 37(4):547-555.
    View in: PubMed
    Score: 0.026
  2. Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial. Front Med. 2021 Jun; 15(3):486-494.
    View in: PubMed
    Score: 0.008
  3. The effect of a novel minimally invasive strategy for infected necrotizing pancreatitis. Surg Endosc. 2017 11; 31(11):4603-4616.
    View in: PubMed
    Score: 0.006
  4. Different antiviral effects of IFNa subtypes in a mouse model of HBV infection. Sci Rep. 2017 03 23; 7(1):334.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.